Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026 (forecast)
2027
2028
2029
2030
2031
Trend
ROE
24.73%
27.14%
24.3%
22.61%
22.19%
20.3%
17.96%
Sector average
-
13.51%
12.5%
10.1%
-79.46%
12.09%
13.16%
ROA
17.23%
18.15%
16.34%
16.03%
16.26%
15.32%
13.97%
Sector average
-
7.65%
7.54%
7.58%
7.74%
Amounts in SAR (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as ā-ā. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Middle East Pharmaceutical Industries Company? It covers the balance sheet, income statement and Equlion model projections.
7.42%
7.75%
Gross Margin
62.29%
62.3%
62.3%
62.3%
62.3%
62.3%
62.3%
Sector average
-
35.13%
35.13%
35.13%
35.13%
35.13%
32.65%
Net Margin
21.07%
21.21%
21.25%
21.28%
21.5%
21.6%
21.68%
Sector average
-
10.87%
11.04%
10.98%
11.17%
11.25%
12.14%
Total Assets
SARĀ 599.53M
SARĀ 689.41M
SARĀ 819.58M
SARĀ 988.82M
SARĀ 1,202.46M
SARĀ 1,429.12M
SARĀ 1,659.82M
Sector average
-
SARĀ 3,177.89M
SARĀ 3,554.62M
SARĀ 4,038.94M
SARĀ 4,611.04M
SARĀ 5,154.00M
SARĀ 6,248.92M
Net Income
SARĀ 97.01M
SARĀ 116.95M
SARĀ 123.26M
SARĀ 144.98M
SARĀ 178.20M
SARĀ 201.58M
SARĀ 215.82M
Sector average
-
SARĀ 258.37M
SARĀ 297.68M
SARĀ 342.59M
SARĀ 402.77M
SARĀ 440.01M
SARĀ 448.74M
Valuation
-
SARĀ 2,168.23M
SARĀ 2,213.68M
SARĀ 2,256.70M
SARĀ 2,289.07M
SARĀ 2,321.32M
SARĀ 2,363.60M
Sector average
-
SARĀ 6,280.05M
SARĀ 6,391.59M
SARĀ 6,501.26M
SARĀ 6,596.14M
SARĀ 6,709.36M
SARĀ 5,496.57M
Stock Price
-
SARĀ 61.95
SARĀ 63.25
SARĀ 64.48
SARĀ 65.40
SARĀ 66.32
SARĀ 67.53
Sector average
-
SARĀ 56.52
SARĀ 57.60
SARĀ 58.69
SARĀ 59.61
SARĀ 60.65
SARĀ 56.24
Middle East Pharmaceutical Industries Company (4016.SR) Financial Forecast | Equlion